Cannabics Pharmaceuticals Launches a New Research Program to develop a Melanoma Treatment Drug Candidate for FDA Approval Track

CANNANNEW REPORT

TEL AVIV, Israel and BETHESDA, Maryland, April 26, 2021 /PRNewswire/ — Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in… Read More…..

Excerpt only …
READ MORE BELOW
Source : Cannabics Pharmaceuticals Launches a New Research Program to develop a Melanoma Treatment Drug Candidate for FDA Approval Track

reposted by Cannabis News World

This site uses Akismet to reduce spam. Learn how your comment data is processed.